Funding Opportunities Related To COVID-19

Last updated on August 8, 2020

The OSR, Office of Clinical Trial Activation (OCTA), and Contracts and Grants Accounting (CGA) are working to ensure continuity of services for researchers, as well as prioritizing COVID-19 research and clinical trials.

Go to our COVID-19 page for sponsor specific guidance, the impact of research and additional resources

Please visit the Office of Research COVID-Related Research website to find a searchable list of all COVID related funding opportunities

 

Please notify your RSC of any intention to submit a proposal ASAP.

Below is a list of NIH funding opportunities only.  The charts below are separated by:

These funding opportunities are also part of the searchable list on the Office of Research COVID website

NIH - National Institutes of Health

Go to the NIH COVID-19 Information for NIH Applicants and Recipients page for a complete list of Funding Opportunities Specific to COVID-19

OD - NOT-OD-20-118 Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency

Related NOSIs: NOT-AT-20-011, NOT-MD-20-019, NOT-AG-20-022, NOT-ES-20-020, NOT-AA-20-011, NOT-HG-20-030, NOT-GM-20-025, NOT-MH-20-047,NOT-OD-20-097, NOT-DA-20-047, NOT-LM-20-010, NOT-OD-20-107 

 

NCI - NOT-CA-20-082 NOSI: NCI Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19) Rolling Submission from July 2, 2920 through August 14, 2020

 

NCI - NOT-CA-20-065 Request For Information (RFI): Strategy for Research in Coronavirus Serology Testing and Serological Sciences, Response Due: May 26, 2020

 

NCI - NOT-CA-20-054 Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be redirected to COVID-19-Related Research During the Crisis

 

NHLBI - Research Opportunity Announcement (ROA) OTA-20-011 ACTIV Integration of Host-targeting Therapies for COVID19 Stage 1 Letters of Request Due: Friday, May 15, 5 PM EDT. Additional letters of request considered on a monthly basis June 15, July 15, and August 15.

 

NIBIBNIH POCTRN - Fast-Track Program for COVID-19 Test Development and Distribution Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing Rolling Submission from April 29, 2020 until further ntoice.

 

COVID-19 Applications:

NIH IC NOSI NOSI Expiration Title FOAs Used

OD/NHLBI/

NIAID/NIAMS/

NICHD/NIDA/

NIMHD/FIC

     
  • RFA-OD-20-023 Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional) Letter of Intent Due Date: August 31, 2020/Application Due Date: September 30, 2020

OD/NIA/

NICHD/

NIDCD/

NIDCR/

NINDS/

NINR/NLM

     
  • RFA-OD-20-022 Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional) Due Date: September 15, 2020
  • Related Competitive Revision NOSI: NOT-OD-20-152

 OD/NHLBI/

NIAAA/NIAMS/

NIBIB/NICHD/

NIDCR/NIMHD/

NLM/NCATS

     
  • RFA-OD-20-021 Emergency Awards: RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)Letter of Intent Due Date: August 18, 2020/Application Due Date: September 18, 2020 
  OD/NHLBI/

NIAAA/NIAMS/

NIBIB/NICHD/

NIDCR/NIMHD/

NLM/NCATS

     
  • RFA-OD-20-020 Emergency Awards: RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed) Letter of Intent Due Date: August 18, 2020/Application Due Date: September 18, 2020

OD/NIMHD/NIA

NHLBI/NICHD/

NIDCD/NIDCR/NIDA/

NIEHS/NIGMS/NIMH/

NINR/NLM/NCCIH/

NCATS/NCI/NIAID/

NIDDK/NIAAA

     
  • RFA-OD-20-019 Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed) Due Date: September 15, 2020
  • Related Competitive Revision NOSI: NOT-OD-20-152NOT-OD-20-159

 OD/NHLBI/

NHGRI/NIA/NIDCR/

NIDA/NCATS/NCI/

Common Fund

     
  • RFA-OD-20-018 Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) Letter of Intent Due Date: August 18, 2020/Application Due Date: September 18, 2020

   OD/NHLBI/

NIAAA/NIAMS/

NIBIB/NICHD/

NIDCR/NIMHD/

NLM/NCATS

     
  • RFA-OD-20-017 Emergency Awards: RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed) Letter of Intent Due Date: August 18, 2020/Application Due Date: September 18, 2020

OD/NIAAA/NIDCR/

NIDDK/NIDA/NIGMS/

NINR/NIMHD/NLM

     
  • RFA-OD-20-016 Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional) Letter of Intent Due Date: August 30, 2020/Application Due Date: September 30, 2020

OD/NIDA/NIEHS/

NIGMS/NLM

     
  • RFA-OD-20-015 Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed) Letter of Intent Due Date: August 15, 2020 Application Due Date: September 15, 2020

OD/NIA/NIAAA/NICHD/

NCCIH/NCI/NHLBI

     
  • RFA-OD-29-014 Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed)  Letter of Intent Due Date: August 21, 2020/Application Due Date: September 15, 2020

OD/NIMHD/NIA

NEI/NHLBI/NHGRI/

NIAMS/NIBIB/NICHD/

NIDCD/NIDCR/NIDA/

NIEHS/NIGMS/NIMH/

NINR/NLM/FIC/NCCIH/

NCATS/NCI/NIAID/

NIDDK/NIAAA/NINDS

     
  • RFA-OD-20-013 Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC)(U24 Clinical Trial Optional) Due Dates: Letter of Intent, July 8, 2020;  Application, August 7, 2020 No late applications will be accepted for thei FOA
  • Related Competitive Revision NOSIs: NOT-OD-20-121, NOT-OD-20-120, NOT-OD-20-119

NIMHD/NEI/NIA/

NIAAA/NICHD/NIDCD/

NIDCR/NIDDK/NIDA/

NIEHS/NIMH/NINR/

NCCIH/NCATS/ODP/

ORWH/SGMRO

     
  • PAR-20-237 Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01 Clinical Trial Optional) Due Dates: August 28, 2020 OR December 1, 2020 

NHGRI/NICHD/

NIMH/NINDS

     
  • RFA-HG-20-039 Laboratory, Data Analysis, and Coordinating Center (LDACC) for the Developmental Genotype-Tissue Expression Project (U24 Clinical Trial Not Allowed) Due Dates: Letter of Intent-October 13, 2020; Application-November 13, 2020
NIA      
  • PAR-20-234 NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) Due Dates: July 1, 2020, August 3, 2020, September 1, 2020, October 1, 2020, November 2,2020, December 1, 2020, January 4, 2021, and February 1, 2021 
NIAID      
  • PAR-20-177 Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) Due: Rolling Basis from April 30, 2020 -  April 29, 2021 August 14, 2020 beyond this date applicants are encouraged to consider applying for
  • PA-20-195 NIH Exploratory Developmental Research Grant Program (Parent R21 Clinical Trail Not Allowed)
  • PAR-20-178 Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Included) Due: Rolling Basis from April 30, 2020 - April 29, 2021 August 14, 2020 beyond this date applicants are encouraged to consider applying for
  • PA-19-056 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
NIH Office of Strategic Coordination      
  • RFA-RM-20-020 NIH Director's Emergency Tranformative Research Awards (R01 Clinical Trial Optional Due: September 30, 2020
  • RFA-RM-20-021 NIH Director's Emergency Early Independence Awards (DP5 Clinical Trial Optional) Due: September 4, 2020 
NICHD      
  • RFA-HD-20-028 LIMITED COMPETITION: Data Coordinating Center (DCC) for Completion of Ongoing MFMU Network Protocols (U24 Clinical Trial Optional) Due Date: September 4, 2020
  • RFA-HD-20-029 LIMITED COMPETITION: Clinical Centers for Compoletion of Ongoing MFMU Network Protocols (UG1 Clinical Trial Optional) Due Date: September 4, 2020
NIAID NOT-AI-20-051 9/8/21 Select Research Areas for Severe Acute-Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
  • PA-20-200 NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) Standard Due Dates apply, first Standard Due Date is June 16, 2020. Standard AIDS Dates apply, first Standard AIDS Date is September 7, 2020 
  • PA-19-272 PHS 2019-02 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent  SBIR R43/R44 Clinical Trial Not Allowed) Standard Due Dates apply (AIDS Due Date - not applicable)
  • PA-19-270 PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR R41/R42 Clinical Trial Not Allowed) Standard Due Dates apply (AIDS Due Date - not applicable)
OPPNET, NIA, NIAAA, NICHD, NIDA, NIMH, NINDS, NINR, NIMHD, NCCIH, OBSSR NOT-OD-20-103 3/18/21 Notice of Additional Due Date and Additional "Areas of Focus Especially of Interest" of PAR-19-373 and PAR-19-384
  • PAR-19-373 Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01-Clinical Trials Not Allowed) Due: 6/8/20, 3/17/21
  • PAR-19-384 Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01-Basic Experimental Studies with Humans Required) Due: 6/8/20, 3/17/21
NIDA

NOT-DA-20-058

1/8/24

Utilizing Telemedicine or Other Remote-Based Platforms to Develop and Support Treatments for Substance Use Disorders

  • PA-20-185 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) DUE: Standard Due Dates on or after October 5,2020 through January 8, 2024
  • PA-20-183 Research Project Grant (Parent R01 Clinical Trial Required) DUE: Standard Due Dates on or after October 5,2020 through January 8, 2024
  • PA-20-195 NIH Exploratory Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) DUE: Standard Due Dates on or after October 5,2020 through January 8, 2024
  • PA-20-194 NIH Exploratory Developmental Research Grant Program (Parent R21 Clinical Trial Required) DUE: Standard Due Dates on or after October 5,2020 through January 8, 2024
NIDCD

NOT-DC-20-008

9/8/20

NIDCDE is Interested in Supporting Research on the Impact of COVID-19 on Mission specific Sensory and Communication Disorders

This NOSI applies to due dates on or after October 5, 2020 and subsequent receipt dates through September 8, 2022

  • PA-18-334 NIDCD Clinical Trials in Communication Disorders (R01 Clinical Trial  Required) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-20-185 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-20-184 NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-20-196 NIH Exploratory Development Research grant Program (Parent R21 Basic Experimental Studies with Humans Required) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-20-195 NIH Exploratory Developmental Research Grant Program (R21 Clinical Trial Not Allowed) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-20-194 NIH Exploratory Developmental Research Grant Program (Parent R21 Clinical Trial Required) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-19-270 PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR R41/R42 Clinical Trial Not Allowed) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-19-271 PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR R41/R42 Clinical Trial Required) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-19-273 PHS 2019-02 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR R43/R44 Clinical Trial Required) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-19-272 PHS 2019-02 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR R43/R44 Clinical Trial Not Allowed) Standard Due Dates on or after 10/5/20 throuth 9/8/22
NIDCR

NOT-DE-20-023

FAQs

  Infrastructure Access for Research on Coronavirus disease 2019 (COVID-19) Conducted in the National Dental Practice-based Research Network
  • PAR-20-073 National Dental Practice-based Research Network Infrastructure Access (X01 Clinical Trial Not Allowed) Due: 6/1/20, 9/1/20, 11/2/20, 9/1/21, 9/1/22
NIDDK      
  • RFA-DK-20-011 Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required) Due Date: November 4, 2020
  • RFA-KD-20-012 Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required) Due Date: November 4, 2020
  • RFA-DK-20-021 Mechanistic Studies of the Interaction between SARS=CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) LOI Due Date: November 16, 2020, Application Due Date: December 16, 2020
NCATS NOT-TR-20-012 10/17/20 Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)
  • PA-18-462 Clinical Trial Planning Therapeutic/Indication Pairing Strategies (U34 Clinical Trial Not Allowed) Due: 6/16/20, 10/26/20
  • PAR-18-332 Clinic Testing Therapeutic/Indications Pairing Strategies (U01 Clinical Trial Required) Due: 6/5/20, 10/5/20
NIEHS

NOT-ES-20-015

 Rescinded 4/10/20

replaced by NOT-ES-20-20

4/9/20 NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
  • RFA-ES-19-011 Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) Due: see RFA

 

  TOP

COVID-19 Supplements for Exisiting Awards:

NIH IC

COVID NOSI

Competitive

PA-20-135 expands scope

Competitive 

PA-18-935 

expands scope

Adminis. 

 PA-18-591

within scope

Noted

Requirements

(please see

NOSI for all

requirements

specified)

Deadline Release Expires

OD/NLM

NOT-OS-20-159 X    

Also see:

RFA-OD-20-019

8/21/20 8/6/20 8/22/20

OD/NIA/

NICHD/

NIDCD/

NIDCR/

NINDS/

NINR/

NOT-OD-20-152 X    

Also see:

RFA-OD-20-022

RFA-OD-20-019

9/15/20 8/6/20 9/16/20

OD/

NIMHD/

NIA/

NEI/

NHLBI/

NHGRI/

NIAAA/

NIAID/

NIAMS/

NIBIB/

NICHD/

NIDCR/

NIDCD/

NIDDK/

NIDA/

NIEHS/

NIGMS/

NIMH/

NINDS/

NINR/

NLM/

FIC/

NCCIH/

NCATS/NCI

NOT-OD-20-119 X    

Researchers applying to this NOSI are encouraged to read NOT-OD-20-121, NOT-OD-20-120, RFA-OD-20-013

Applicants are strongly encouraged to contact SEBI program officials prior to developing an application to determine programmatic responsiveness to the NOSI

NIH expects that all supplements funded under this NOSI and the related NOSIs will actively coordinate and share data (where allowed) with other grantees, the CDCC, and other research supported by the RADx-UP program

8/7/20 OR 9/8/20 6/12/20 9/9/20

OD/

NIMHD/

NIA/

NEI/

NHLBI/

NHGRI/

NIAAA/

NIAID/

NIAMS/

NICHD/

NIDCR/

NIDDK/

NIDA/

NIEHS/

NIGMS/

NIMH/

NINDS/

NINR/

NLM/FIC/

NCCIH/

NCATS/

NCI

NOT-OD-20-120 X    

Projects awarded under this NOSI will be expected to work collaboratively with the CDCC (RFA-OS-20-013) and the SEBI projects (NOT-OD-20-119) related to COVID-19

Researchers applying to this NOSI are encouraged to read NOT-OD-20-121, NOT-OD-20-119, RFA-OD-20-013

NIH expects that all competing revisions funded under this NOSI will actively coordinate, collaborate, and share date with other testing research projects, the CDCC, and other research supported by SEBI program as allowed and with considerations under tribal IRB processes

8/7/20 OR 9/8/20 6/12/20 9/9/20

OD/

NIMHD/

NIA/

NEI/

NHLBI/

NHGRI/

NIAAA/

NIAID/

NIAMS/

NICHD/

NIDCR/

NIDDK/

NIDA/

NIEHS/

NIGMS/

NIMH/

NINDS/

NINR/

NLM/

NCCIH/

NCATS/

NCI

 

NOT-OD-20-121 X    

The same grant cannot be submitted for consideration under this NOSI and NOT-OD-20-120

Only the NIH programs listed on the NOSI of participating ICs are eligible

Researchers applying to this NOSI are encouraged to read NOT-OD-20-120, NOT-OD-20-119, RFA-OD-20-013

NIH expects that all competing revisions funded under this NOSI will actively coordinate, collaborate, and share date with other testing research projects, the CDCC, and other research supported by SEBI program as allowed and with considerations under tribal IRB processes

 

8/7/2020 6/12/20 8/8/20
NIAID

NOT-AI-20-059

X    

Specific areas of support limited to active BSL3 facilities, generation of critical reagents, expansion of relevant data systems, expansion of CT infrastructure.

See Notice for details

Rolling basis from 7/2/20 to 7/2/21 7/6/20 7/2/21
NIAID

NOT-AI-20-034

Rescinded 7/6/20

Replaced by NOT-AI-20-059

X     FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25  Rolling basis from 3/25/20-3/25/21  3/25/20  3/25/21
NIAID

NOT-AI-20-031

Rescinded 5/19/20

Replaced by NOSI NOT-AI-20-051 R03, R41/R42, R43/R44 

or use

PAR-177 PAR-178

See Application Grid above

    X

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25

 Rolling basis from 4/5/20-4/5/21  3/27/20

 4/5/21

5/19/20

NIBIB NOT-EB-20-008 X   X

Limited to DP1, DP2, P41, R00, R01, R03, R15, R21, R24, R37, R41, R43, R44, R56, U01, U18, U24, U2C, U54, UG3, UH2, UH3

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25

Rolling basis from 4/2/20-11/10/20 4/10/20 11/10/20
NCATS NOT-TR-20-017 X    

Only existing UG3/UH3, R43/R44, R41/R42, R01, U01 NCATS/NIH Microphysiological Systems

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25

Rolling basis from 5/15/20-1/25/22 4/9/20 1/26/22
NCATS NOT-TR-20-028 X   X

Soliciting current CTSA UL1 & U24 recipients of

RFA-TR-17-006 RFA-TR-15-004 PAR-18-940 UL1 component only   PAR-18-464 UL1 component only     PAR-15-304 UL1 component only  RFA-TR-14-009 UL1 Component only                 

Admin. Supp. Cannot use streamline submission in eRA.

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Rolling basis from 5/4/20-11/11/20 4/23/20 11/11/20
NCATS NOT-TR-20-029     X

Soliciting current CTSA UL1 & U24 recipients of

RFA-TR-17-006 RFA-TR-15-002 RFA-15-TR-004 PAR-18-940 UL1 component only   PAR-18-464 UL1 component only     PAR-15-304 UL1 component only   RFA-TR-14-009 UL1 Component only 

Admin. Supp. Cannot use streamline submission in eRA.

Awarded using appropriations provided by the H.R.748 (PL 116-136) CARES Act issued in unique subaccounts in the PMS and will require separate financial reporting 

Rolling basis 6/15/20 - 11/10/20 6/15/20 11/11/20
NIAAA

NOT-AA-20-011

See

NOT-OD-20-118

Data Sharing Expectations

  X X

Admin. Supp. Cannot use streamline submission in eRA.

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Rolling basis 5/15/20-4/16/21 4/16/20 4/16/21

NIA/

NIMH

NOT-AG-20-022

FAQs

See

NOT-OD-20-118

Data Sharing Expectations

  X X

Admin. Supp. Cannot use streamline submission in eRA.

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Rolling basis from 4/6/20-5/1/21 4/2/20 5/21/21

NCCIH/

ORWH

NOT-AT-20-012   X X

Only existing awardees of NCCIH active awards.

Admin. Supp. Cannot use streamline submission in eRA.

PA-18-591 and PA-18-935 were reissued with FORMS-F on 5/25/20

Applications started using FORMS-E must be completed by 6/25/20

Rolling through 8/17/20 5/26/20 8/18/20

NCCIH/

NIA/

NIAAA

NOT-AT-20-011

See

NOT-OD-20-118

Data Sharing Expectations

  X X

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/25/20

Rolling basis from 4/10/20-10/6/20 4/10/20 10/7/20
NIDA

NOT-DA-20-047

See

NOT-OD-20-118

Data Sharing Expectations

  x x

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/25/20

Rolling basis from 3/19/20-3/31//21 3/19/20 3/31/21
NIDCR

NOT-DE-20-022

FAQs

  X X

Includes R42, R44, SB1, K01, K08, K23, K25, K99/R00, R01, R15, R37, U01, U19, UH3

Admin. Supplement cannot use streamline submission in eRA Commons

Must use application form package with the Competition ID that contains FORMS-F-ADMINSUPP

6120 and 11/2/20 5/5/20  
NIGMS

NOT-GM-20-025

See

NOT-OD-20-118

Data Sharing Expectations

  X    

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25

 Rolling basis from 3/25-2/5/21  3/25/20  2/6/21
NHLBI

NOT-HL-20-782

X    

Phase I-III CT, parent P01, R01, R33, R41, R42, R43, R44, U01, U24, U54, UH3, UM1

OA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Rolling basis from 5/1/20-10/5/20 4/27/20 10/6/20
NHLBI

NOT-HL-20-757

FAQs

Expires 5/15/20

see

NOT-HL-20-782

or

OTA-20-011

  X X

Admin. Supp. Cannot use streamline submission in eRA.

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Contact with NHLBI progran staff well in advance is strongly recommended.

 Rolling basis from 3/17-05/15/20  3/17/20  5/15/20

NLM

NOT-LM-20-010

See

NOT-OD-20-118

Data Sharing Expectations

    X

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25

6/1/20 4/16/20 6/2/20

NIMHD/

NEI/

NHLBI/

NIA/

NIAAA/

NICHD/

NIDCD/

NIDCR/

NIDDK

NIDA/

NIEHS/

NIMH/

NCCIH/

NCATS/

SGMRO

NOT-MD-20-022

CHANGES:

NOT-HL-20-802 announces NHLBI withdrawal effective 8/2/20

  X X

Admin Supplement must use form package with Competition ID FORMS-F-ADMINSUPP

Admin. Supplement cannot use streamline submission in eRA Commons

Competitive Revision must use form package with Competition ID FORMS-F-COMP-REV

Rolling basis from 6/10/20 through 12/15/20 6/5/20 12/20/20

NIMHD

NIA/

NIMH

NOT-MD-20-019

See

NOT-OD-20-118

Data Sharing Expectations

  X X

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Rolling basis from 5/1/20-5/1/21 4/9/20 5/1/21

NIMH/

NEI/

NHLBI/

NIA/

NIAAA/

NICHD

NIDCD/

NIDCR/

NIDDK/

NIDA/

NINR/

NIMHD/

NCCIH/

NCATS/

SGMRO

NOT-MH-20-053   X X

Admin Supplement must use form package with Competition ID FORMS-F-ADMINSUPP

Admin. Supplement cannot use streamline submission in eRA Commons

Competitive Revision must use form package with Competition ID FORMS-F-COMP-REV

Rolling basis from 6/10/20 through 12/15/20 6/5/20 12/30/20

NIMH

NIA/

NIAAA/

NIMHD/

ODP

NOT-MH-20-047

See

NOT-OD-20-118

Data Sharing Expectations

  X X

May be co-funded by ODP

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Rolling basis from 3/27/20-4/15/21 4/9/20 4/16/21

NINDS

NOT-NS-20-046   X X

Active U01 or U24 for FOA RFA-NS-19-024, RFA-NS-17-02, RFA-NS-16-015, RFA-NS-13-016, RFA-NS-11-010

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25

Rolling basis from 4/6/20-5/8/20 4/14/20 5/9/20

NINDS

NOT-NS-20-051

NOT-NS-20-074 adds RF1 to eligible mechanisms

  X X

Limited to P01, P50, RF1,R00, R01, R03, R15, R33, R35, R41, R42, R43, R44, R61, U01, U19, U24, U44, U54, UG3, UH3

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25

Rolling basis from 4/15/20-4/14/21 4/30/20 4/15/21

OD

Office of

the

Director

 

NOT-OD-20-107

See

NOT-OD-20-118

Data Sharing Expectations

    X

EsixtingECHO Cohorts, Coordinating Center, Data Analysis Center and PRO Core Awardees

Existing Subawardees not eligible

Use application form package with Competition ID that contains FORMS-F-ADMINSUPP

6/22/20 5/27/20 6/23/20

OBSSR/

NHLBI/

NIA/

NIAAA/

NIDDK/

NIEHS/

NCCIH/

NCI

NOT-OD-20-097

See

NOT-OD-20-118

Data Sharing Expectations

  X X

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25

Rolling basis from 4/13/20-3/31/21 4/13/20 4/1/21

NCATS

NOT-TR-20-011     X

Supplements U01-PAR-19-099 R21-PAR-19-100 UL1-PAR-19-337

Admin. Supp. cannot use streamline submission in eRA Commons.

FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25

5/4/20 AND 11/2/20 3/24/20 7/10/21

NCATS

NOT-TR-20-016     X

Admin. Supp. cannot use streamline submission in eRA Commons.

FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25

Rolling basis from 5/15/20-1/25/22 4/9/20 1/26/22

NIAID

NOT-AI-20-040      

Early termination of NOT-AI-20-030 (expires 4/8/20). Please use NOT-AI-20-034 and NOT-GM-20-025 (listed above)

    4/8/20

 TOP

 

 Go to our COVID-19 page for sponsor specific guidancethe impact of research and additional resources